A B S T R A C T Among 25 patients with benign, essential hypertension, and an equal number with other benign forms of hypertension, without serious cardiac, renal, or cerebrovascular impairment, 41 cases failed to reduce aldosterone excretion rates into the normal range (less than 5 Ag/day) on a daily intake of 300 mEq of sodium. The hypertensive patients excreted slightly less than the normal fraction of labeled aldosterone as acidhydrolyzable conjugate. Secretion rates were significantly higher in the hypertensive patients than in normotensive controls taking the high-sodium intake.
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On a 10 mEq sodium intake, the increase in excretion and secretion rates of aldosterone in the hypertensive patients could be correlated with plasma renin activity (PRA). The patients with the least increase in PRA had subnormal increase in aldosterone secretion and excretion, while unusually large rises in aldosterone secretion accompanied high PRA, especially in the cases with increased plasma angiotensinogen induced by oral contraceptives.
The persistence of inappropriately high aldosterone secretion in most hypertensive patients during sodium loading could be related to a higher PRA than that found in normotensive controls under comparable conditions. In other hypertensives, whose PRA was unresponsive to sodium depletion, there was no significant correlation between PRA and aldosterone output, and no known stimulus to aldosterone production was detected. Five obvious cases of hyperaldosteronism were found among the 16 low-renin patients. The cause of the nonsuppressible aldosterone production in the other -low-renin cases remains to be determined.
INTRODUCTION
Is aldosterone secretion rate normal in benign, essential hypertension? Earlier reports (1) (2) (3) suggested that aldosterone excretion rate was increased in as many as 25% of hypertensive patients, some of whom might be unrecognized cases of primary aldosteronism (4) . Other observers found that hyperaldosteronism was common in malignant hypertension, but increased secretion rate was rarely found in benign, essential hypertension unless complicating cardiovascular or renal disease existed (5) (6) (7) (8) (9) . Most of the patients in the foregoing studies received diets containing between 100 and 150 mEq sodium per day.
Aldosterone production in normal man is strongly influenced by sodium intake (10, 11) . In examining the physiological range of secretion rate, it is essential to define the response to a wide range of sodium loads. We suggest that under heavy sodium loads, hypertensive patients may not show the normal degree of suppression of aldosterone secretion (12) . Secretion rate may also fail to increase normally during sodium depletion in 'certain hypertensive patients (13) .
The effect of sodium intake on aldosterone secretion is thought to be mediated principally by the reninangiotensin system (14) . Plasma renin activity (PRA) has been found to be closely correlated with aldosterone secretion and excretion in normal men (11) and in many hypertensive patients (12, 13) . By comparing PRA with aldosterone secretion at different levels of dietary sodium, it is possible to detect abnormalities of aldosterone regulation. The results of these analyses have been related to the clinical data and diagnosis. Eight patients developed hypertension while taking oral contraceptive (Appendix E and Table IV ). As previously reported (15, 16) , blood pressure fell gradually when oral contraceptive was withheld. Eight patients were studied after medication was discontinued (Appendix E and Table  V) .
In five cases, the laboratory findings were considered diagnostic of primary aldosteronism (4) . Two have been explored surgically. Excision of an adenoma in case 20 resulted in cure. Improvement in hypertension and metabolic abnormalities in case 69 followed removal of both adrenal glands, which were enlarged and contained numerous small nodules. Three other patients are under observation on aldosterone-blocking agents.
Plan of study. Normal volunteers and hypertensive patients were asked to take liberal salt intake and to discontinue all medications (except as stated) before admission to the hospital. After entering the General Clinical Research Center, all patients received a diet containing at least 300 mEq of sodium per day for 3 days or until the sodium excretion exceeded 300 mEq/day. Sodium intake was then reduced to less than 10 mEq/day for a period of 5 days or until the urinary sodium fell below the intake. Aldosterone secretion rate was measured by isotope dilution on the 2nd day of the high-sodium intake and on the 3rd and 5th days of the low-sodium regimen. Aldosterone excretion rate was determined by the double-isotope derivative assay on other representative days of the high-sodium and low-sodium periods.1 Plasma renin activity (PRA) was measured by the method of Boucher and Genest (18) (Table I) .
Benign, essential hypertension (Table II) . In 20 of 25 patients, urinary aldosterone did not decrease to a normal extent on a sodium intake of 300 mEq. The mean for the group was more than three times as high as the average of the normal control group. The difference between means was significant at the level of P = 0.001. The response to sodium deprivation was highly variable. Renal artery stenosis and various renal disorders (Table III) . A small group of patients of each type were studied. Three-fourths of the patients had abnormally high aldosterone excretion on a 300 mEq intake of sodium.
Patients receiving oral contraceptives (Table IV) . Five of eight patients had aldosterone. excretion rates greater than normal on the high-sodium intake. During sodium deprivation, three of eight patients had unusually Aldosterone Secretion in Benign Hypertension 1417 large rises in urinary aldosterone. When moderate hy-peared in two patients (cases 19 and 81) on a second pertension persisted after stopping medication, a lesser study. In both cases, a previous study had shown a dedegree of hyperaldosteronism was noted (Table V) . gree of suppressibility of aldosterone excretion similar Hyperaldosteronism due to adrenal adenomra or idio-to that observed in many other hypertensive patients. pathic adrenal hyperplasia (Table VI) . Aldosterone ex-P cretion above 20 isg/day, not suppressed by high-sodium Plasma renin activity intake, distinguishes these cases from other "low-renin"
Normotensive controls (Table VII, group 1) . PRA hypertensives. Abnormally high aldosterone output ap-was inversely related to sodium intake, and was higher The mean and standard error of PRA for each group is given in Table VII . "High PRA" was most readily observed during salt loading, when PRA in the normotensive controls was at a minimum (Table VII) . High PRA in hypertensive patients was often attributed to increased renin concentration or cofactors, with normal substrate levels (group 3a). Hypertensive patients receiving oral contraceptives have been considered separately (group 3b), since plasma angiotensinogen was consistently increased 3-5 times above normal (16) . The associated increase "Low PRA" was defined as being clearly below the normal range of PRA in all observations made during the low-sodium diet. As there was considerable overlap with the normal series on a high-sodium intake, this group could also be characterized as "unresponsive" to sodium depletion. Our criteria for "low PRA" agree with those of Cohen, Conn, and Rovner (19). 5 Relation between aldosterone excretion and PRA Normotensive controls (group 1). Aldosterone excretion rate showed a strong, positive correlation (r = 0.89) with PRA in the normotensive controls. Values of PRA in blood drawn from standing subjects are shown in Fig. 1 and have been used in calculating correlations with aldosterone.
Hypertension with normal PRA (group 2) or high PRA (group 3a). As shown in Table VIII , mean aldosterone excretion in these hypertensive patients was significantly higher than in normotensive controls during sodium loading. When dietary sodium was reduced below 10 mEq/day, aldosterone excretion increased to a normal level. Aldosterone excretion and PRA showed a significant, positive correlation (Figs. 2 and 3) . The slopes of the regression lines did not differ significantly from normal, and almost all individual data points fell within the 95% confidence limits of the observations on normotensive controls.
Hypertension with high angiotensinogen and high PRA (group 3b). Patients taking combinations of estrogen and gestagen had the highest average PRA and aldosterone levels of any group, both during salt loading and after sodium deprivation (Table VIII) . The relationship between PRA and aldosterone excretion was similar to that in the normotensive controls (Fig. 1) . Individual observations were consistently within the 95% confidence limits of the normotensive series, and the regression lines were virtually identical.
Hypertension with low PRA (group 4). Aldosterone excretion was above normal in 11 of the 13 patients on high-sodium intake. On the 10 mEq sodium diet, aldosterone excretion rose only slightly, reaching a level far below the averages observed in the other normotensive and hypertensive patients (Table VIII) . The correlation between aldosterone and PRA was weak (r = 0.189), and the slope of the regression was significantly below that for normal and hypertensive groups 1-3. Hypokalemia occurred frequently in patients with inappropriately high aldosterone excretion rates (Fig. 4) above 20 gg/day (Tables VI and VII) , and a low serum potassium concentration after sodium loading (Appendix F). The normal correlation between PRA and aldosterone excretion was lacking (Fig. 4) .
Aldosterone secretion rate
Aldosterone secretion rates in the normotensive control group varied inversely with sodium intake. The mean secretion rate in normotensive controls taking between 100 and 150 mEq sodium per day was 102 ilg, whereas in those taking between 150 and 230 mEq it was 82.8. In the normotensive controls taking 300 mEq sodium or more per day, there was no difference between the active and inactive groups, the means being respectively 32.0 and 32.1 /Ag/day. On a 10 mEq sodium diet, secretion rate increased to a mean of 673 /Ag/day.
In the hypertensive patients on a high sodium intake, aldosterone secretion rates were significantly higher than in the normotensive controls (Table IX) . During sodium deprivation, the low-renin hypertensive patients (group 4) had distinctly lower aldosterone secretion than either normal controls or any other hypertensive group. By the 5th day of the low-sodium diet, the average hypertensive patient with normal plasma renin activity secreted less aldosterone than the normotensive control average. 1-9, 21 ). Higher than normal secretion rates have been observed in primary aldosteronism, in malignant hypertension, and in some cases of renovascular hypertension. In benign, essential hypertension, aldosterone secretion has been considered to be normal or increased. In the present report, we have measured aldosterone secretion and plasma renin activity in normotensive controls and in patients with benign hypertension, both on a high and a low intake of sodium. Our aim is to define the circumstances in which aldosterone secretion may be abnormal and to suggest the nature of the disordered regulation.
When normal men ingest above 300 mEq of sodium chloride per day, aldosterone secretion rate falls to very low levels (mean 32.7 /Ag/day), and excretion rates decline to 5 ig or less per day. Under similar conditions, between 70 and 80% of patients with benign, essential hypertension continue to excrete more than 5
Mg/day. The average secretion rates in essential and other forms of benign hypertension are 3-6 times the normal rate on the high-sodium intake.
When sodium intake was restricted to 10 mEq/day, aldosterone secretion increased as expected in the normotensive controls. Patients with hypertension had a much greater range than the normal group. In the patients with low plasma renin activity, aldosterone secretion was much below the normal range on the lowsodium diet. Patients with high plasma renin activity, especially those taking oral contraceptives, had unusually large increases in aldosterone secretion during sodium depletion. It seems likely that much of the variation in aldosterone secretion and excretion among patients on the low-sodium intake can be related to variation in the plasma renin activity.
Patients with normal or increased PRA have a normal relationship between PRA and aldosterone secretion. In these hypertensive patients, high PRA could account for the increase in basal aldosterone production. In the low-renin hypertensives, however, the smaller changes in plasma renin activity were not accompanied by corresponding changes in aldosterone production. Another factor must be assumed to explain abnormal secretion rate in these circumstances, unless a completely different relationship between angiotensin release and aldosterone production exists (22) . The other factor is not ACTH, as judged from the normal levels of plasma cortisol and urinary 17-hydroxycorticoids found in the low-renin patients.
The state of body potassium and serum potassium concentration must also be taken into account. Hypokalemia is uncommon in these cases, it is not associated with unusually high aldosterone secretion. Ledingham, Bull, and Laragh (11) described low aldosterone production and high plasma renin activity in a small group of hypertensive patients, and found that a normal relationship between aldosterone and plasma renin activity was restored after giving potassium salts.
A different situation exists in patients with low plasma renin activity, in whom hypokalemia occurs most commonly at high levels of aldosterone production. Hyperaldosteronism is clearly present when secretion rate exceeds 200 Ag/day. Other patients with hypokalemia have secretion rates below 200 ug, but higher than the usual hypertensive patient's nonsuppressible secretion rate of about 100 /hg/day. Replacement of the potassium deficit may raise aldosterone production rate into a range compatible with the diagnosis of primary aldosteronism or idiopathic adrenal hyperplasia (23, 24) .
There remains a group of patients with essential hypertension and low plasma renin activity, who are normokalemic, but whose aldosterone production, at the upper limits of normal, seems out of proportion to the low PRA. Woods, Liddle, Stant, Michelakis, and Brill (25) have described similar patients who secrete an inappropriate quantity of adrenal mineralocorticoid, who have higher extracellular fluid volume than other hypertensive patients, and who have a greater fall in blood pressure when an inhibitor of adrenal biosynthesis, glutethimide, is administered. These patients are frequently salt losers on a low-sodium regime, as they fail to increase aldosterone production or reduce sodium excretion normally during sodium deprivation (13) .
These observations and hypotheses point out the need for further study of control mechanisms not well understood at present. What factors control the release of renin and the generation of angiotensin in plasma, and why do many patients with benign, essential hypertension fail to suppress PRA and aldosterone production normally after heavy sodium chloride loads? If the reninangiotensin system is not responsible for the sustained aldosterone secretion in patients with low PRA, what underlies the nonsuppressible release of aldosterone, and possibly other corticosteroids, in the patient without an adrenal adenoma?
